Clinical characteristics of asymptomatic and symptomatic pediatric coronavirus disease 2019 (Covid-19): A systematic review

Archive ouverte

Yoon, Sojung | Li, Han | Lee, Keum-Hwa | Hong, Sunghwi | Kim, Dohoon | Im, Hyunjoon | Rah, Woongchan | Kim, Eunseol | Cha, Seungyeon | Yang, Jinho | Kronbichler, Andreas | Kresse, Daniela | Koyanagi, Ai | Jacob, Louis | Ghayda, Ramy Abou | Shin, Jae-Il | Smith, Lee

Edité par CCSD ; MDPI -

International audience. Background and objectives: Characterization of pediatric coronavirus disease 2019 (COVID-19) is necessary to control the pandemic, as asymptomatic or mildly infected children may act as carriers. To date, there are limited reports describing differences in clinical, laboratory, and radiological characteristics between asymptomatic and symptomatic infection, and between younger and older pediatric patients. The objective of this study is to compare characteristics among: (1) asymptomatic versus symptomatic and (2) less than 10 versus greater or equal to 10 years old pediatric COVID-19 patients. Materials and Methods: We searched for all terms related to pediatric COVID-19 in electronic databases (Embase, Medline, PubMed, and Web of Science) for articles from January 2020. This protocol followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Results: Eligible study designs included case reports and series, while we excluded comments/letters, reviews, and literature not written in English. Initially, 817 articles were identified. Forty-three articles encompassing 158 confirmed pediatric COVID-19 cases were included in the final analyses. Lymphocytosis and high CRP were associated with symptomatic infection. Abnormal chest CT more accurately detected asymptomatic COVID-19 in older patients than in younger ones, but clinical characteristics were similar between older and younger patients. Conclusions: Chest CT scan findings are untrustworthy in younger children with COVID-19 as compared with clinical findings, or significant differences in findings between asymptomatic to symptomatic children. Further studies evaluating pediatric COVID-19 could contribute to potential therapeutic interventions and preventive strategies to limit spreading.

Suggestions

Du même auteur

Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): A systematic review of in vitro, in vivo, and clinical trials

Archive ouverte | Han, Youngjoo | CCSD

International audience. Rationale: Coronavirus disease 2019 (COVID-19) has spread worldwide and poses a threat to humanity. However, no specific therapy has been established for this disease yet. We conducted a syst...

Estimation of global case fatality rate of coronavirus disease 2019 (COVID-19) using meta-analyses: Comparison between calendar date and days since the outbreak of the first confirmed case

Archive ouverte | Ghayda, Ramy Abou | CCSD

International audience. Objective: Since the outbreak of the coronavirus disease 2019 (COVID-19) in December of 2019 in China, estimating the pandemic's case fatality rate (CFR) has been the focus and interest of ma...

A comprehensive review of coronavirus disease 2019: Epidemiology, transmission, risk factors, and international responses

Archive ouverte | Li, Han | CCSD

International audience. Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a worldwide pandemic. The first reports of patients with COVID-19 were ...

Chargement des enrichissements...